ClinicalTrials.Veeva

Menu
N

Nucleus Network | Nucleus Network - Melbourne, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

GS-9411
GC4711
Tricaprilin
NNZ-2566
Tislelizumab
ARC-520
Ustekinumab
iN1011-N17
Tocilizumab
ISM5411

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 92 total trials

A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003

Enrolling
Alzheimer Disease
Drug: Aricept Tablet
Drug: IVL3003

A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study in Healthy Adults and Open-label Si...

Invitation-only
Alzheimer Disease
Healthy
Drug: VG-3927
Drug: Placebo

The purpose of this study is to evaluate the relative bioavailability of capsule and tablet formulations of TYRA-300-B01, and to evaluate the safety,...

Enrolling
Healthy
Drug: TYRA-300-B01

A Phase 1 study will assess the safety, tolerability, and pharmacokinetics of Atorvo+™ in healthy adult participants..

Begins enrollment in 1 month
Coronary Heart Disease
Dyslipidemias
Drug: Atorvo+™ +CBD (Arm 3)
Drug: Atorvo+™ +CBD (Arm 2)

This is an open-label, two-part study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-A1811 and preliminary anti-tum...

Active, not recruiting
Advanced Solid Tumors
Drug: SHR-A1811

This is a phase 1, randomized, First in Human (FIH), double-blinded, placebo-controlled study to assess the safety, tolerability, and PK of RSN0402 i...

Enrolling
Idiopathic Pulmonary Fibrosis
Lung; Disease, Interstitial, With Fibrosis
Drug: Placebo
Drug: RSN0402 Part 2

This is a multicenter, observer-blind, randomized, controlled phase 3 study to evaluate the immunogenicity, reactogenicity, and safety of an investig...

Active, not recruiting
COVID-19
Other: Placebo
Biological: Influenza vaccine, adjuvanted

The goal of this clinical trial is to learn about ISM5411 in healthy subjects. The primary objective is to evaluate the safety and tolerability of si...

Enrolling
Healthy Subjects
Drug: ISM5411
Drug: Placebo

The purpose of this study is to evaluate the safety and tolerability of intravenously (IV) administered mRNA-0184 at 2 different infusion durations.

Enrolling
Healthy Participants
Drug: mRNA-0184

Trial sponsors

BeiGene logo
Gilead Sciences logo
Arrowhead Pharmaceuticals logo
R
C
G
I
M
N
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems